102 related articles for article (PubMed ID: 11346432)
1. Effects of difluoromethylornithine chemoprevention on audiometry thresholds and otoacoustic emissions.
Doyle KJ; McLaren CE; Shanks JE; Galus CM; Meyskens FL
Arch Otolaryngol Head Neck Surg; 2001 May; 127(5):553-8. PubMed ID: 11346432
[TBL] [Abstract][Full Text] [Related]
2. alpha-difluoromethylornithine ototoxicity. Chemoprevention clinical trial results.
Pasic TR; Heisey D; Love RR
Arch Otolaryngol Head Neck Surg; 1997 Dec; 123(12):1281-6. PubMed ID: 9413354
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
4. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas.
McLaren CE; Fujikawa-Brooks S; Chen WP; Gillen DL; Pelot D; Gerner EW; Meyskens FL
Cancer Prev Res (Phila); 2008 Dec; 1(7):514-21. PubMed ID: 19139001
[TBL] [Abstract][Full Text] [Related]
6. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
[TBL] [Abstract][Full Text] [Related]
7. [The relations between otoacoustic emissions and pure tone threshold].
Chen J; Zheng Y; Li G; Meng Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 29(18):1591-7. PubMed ID: 26790255
[TBL] [Abstract][Full Text] [Related]
8. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
Gorga MP; Neely ST; Dorn PA; Hoover BM
J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
[TBL] [Abstract][Full Text] [Related]
10. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
Hoth S
Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
[TBL] [Abstract][Full Text] [Related]
11. Comparison of distortion product otoacoustic emissions and pure tone audiometry in occupational screening for auditory deficit due to noise exposure.
Wooles N; Mulheran M; Bray P; Brewster M; Banerjee AR
J Laryngol Otol; 2015 Dec; 129(12):1174-81. PubMed ID: 26549131
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
[TBL] [Abstract][Full Text] [Related]
13. An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study.
Pisani V; Sisto R; Moleti A; Di Mauro R; Pisani A; Brusa L; Altavista MC; Stanzione P; Di Girolamo S
Parkinsonism Relat Disord; 2015 Aug; 21(8):987-91. PubMed ID: 26071125
[TBL] [Abstract][Full Text] [Related]
14. Analysis of subtle auditory dysfunctions in young normal-hearing subjects affected by Williams syndrome.
Paglialonga A; Barozzi S; Brambilla D; Soi D; Cesarani A; Spreafico E; Tognola G
Int J Pediatr Otorhinolaryngol; 2014 Nov; 78(11):1861-5. PubMed ID: 25193583
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic tobramycin treatment on distortion product otoacoustic emissions.
Katbamna B; Homnick DN; Marks JH
Ear Hear; 1999 Oct; 20(5):393-402. PubMed ID: 10526861
[TBL] [Abstract][Full Text] [Related]
16. Irreversible ototoxicity associated with difluoromethylornithine.
Lao CD; Backoff P; Shotland LI; McCarty D; Eaton T; Ondrey FG; Viner JL; Spechler SJ; Hawk ET; Brenner DE
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1250-2. PubMed ID: 15247138
[TBL] [Abstract][Full Text] [Related]
17. Otoacoustic emissions in early noise-induced hearing loss.
Shupak A; Tal D; Sharoni Z; Oren M; Ravid A; Pratt H
Otol Neurotol; 2007 Sep; 28(6):745-52. PubMed ID: 17721363
[TBL] [Abstract][Full Text] [Related]
18. Hearing screening with portable screening pure-tone audiometer and distortion-product otoacoustic emissions.
Wang YF; Wang SS; Tai CC; Lin LC; Shiao AS
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):285-92. PubMed ID: 12201570
[TBL] [Abstract][Full Text] [Related]
19. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
Fetterman BL
Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
[TBL] [Abstract][Full Text] [Related]
20. Tone-burst and click-evoked otoacoustic emissions in subjects with hearing loss above 0.25, 0.5, and 1 kHz.
Jedrzejczak WW; Kochanek K; Trzaskowski B; Pilka E; Skarzynski PH; Skarzynski H
Ear Hear; 2012; 33(6):757-67. PubMed ID: 22710662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
